[PHARMA] QoQ Annualized Quarter Result on 31-Dec-2016 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
21-Feb-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
31-Dec-2016 [#4]
Profit Trend
QoQ- -26.35%
YoY- -45.74%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Revenue 2,281,018 2,272,522 2,473,176 2,189,022 2,141,608 2,181,982 2,236,780 1.31%
PBT 70,930 75,854 111,108 72,017 90,597 96,050 106,152 -23.55%
Tax -27,065 -17,836 -34,076 -26,158 -28,252 -27,828 -32,272 -11.05%
NP 43,865 58,018 77,032 45,859 62,345 68,222 73,880 -29.33%
-
NP to SH 42,697 56,886 75,692 45,599 61,913 66,748 73,516 -30.36%
-
Tax Rate 38.16% 23.51% 30.67% 36.32% 31.18% 28.97% 30.40% -
Total Cost 2,237,153 2,214,504 2,396,144 2,143,163 2,079,262 2,113,760 2,162,900 2.27%
-
Net Worth 531,892 541,894 544,360 531,169 530,907 524,041 515,906 2.05%
Dividend
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Div 44,973 41,484 41,475 41,457 44,889 46,604 41,417 5.63%
Div Payout % 105.33% 72.93% 54.79% 90.92% 72.50% 69.82% 56.34% -
Equity
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Net Worth 531,892 541,894 544,360 531,169 530,907 524,041 515,906 2.05%
NOSH 259,821 259,279 259,219 259,377 258,979 258,913 258,859 0.24%
Ratio Analysis
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
NP Margin 1.92% 2.55% 3.11% 2.09% 2.91% 3.13% 3.30% -
ROE 8.03% 10.50% 13.90% 8.58% 11.66% 12.74% 14.25% -
Per Share
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
RPS 879.14 876.47 954.09 844.83 826.94 842.74 864.09 1.15%
EPS 16.45 21.94 29.20 17.60 23.91 25.78 28.40 -30.49%
DPS 17.33 16.00 16.00 16.00 17.33 18.00 16.00 5.46%
NAPS 2.05 2.09 2.10 2.05 2.05 2.024 1.993 1.89%
Adjusted Per Share Value based on latest NOSH - 259,377
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
RPS 158.27 157.68 171.60 151.88 148.59 151.39 155.20 1.31%
EPS 2.96 3.95 5.25 3.16 4.30 4.63 5.10 -30.39%
DPS 3.12 2.88 2.88 2.88 3.11 3.23 2.87 5.72%
NAPS 0.369 0.376 0.3777 0.3685 0.3684 0.3636 0.358 2.03%
Price Multiplier on Financial Quarter End Date
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Date 29/09/17 30/06/17 31/03/17 30/12/16 30/09/16 30/06/16 31/03/16 -
Price 4.14 4.58 4.89 5.30 5.58 5.50 5.76 -
P/RPS 0.47 0.52 0.51 0.63 0.67 0.65 0.67 -21.03%
P/EPS 25.16 20.88 16.75 30.12 23.34 21.33 20.28 15.44%
EY 3.97 4.79 5.97 3.32 4.28 4.69 4.93 -13.43%
DY 4.19 3.49 3.27 3.02 3.11 3.27 2.78 31.42%
P/NAPS 2.02 2.19 2.33 2.59 2.72 2.72 2.89 -21.22%
Price Multiplier on Announcement Date
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Date 15/11/17 16/08/17 16/05/17 21/02/17 21/11/16 19/08/16 13/05/16 -
Price 3.82 4.19 4.72 5.12 5.70 5.62 5.60 -
P/RPS 0.43 0.48 0.49 0.61 0.69 0.67 0.65 -24.05%
P/EPS 23.21 19.10 16.16 29.09 23.84 21.80 19.72 11.46%
EY 4.31 5.24 6.19 3.44 4.19 4.59 5.07 -10.25%
DY 4.54 3.82 3.39 3.13 3.04 3.20 2.86 36.04%
P/NAPS 1.86 2.00 2.25 2.50 2.78 2.78 2.81 -24.02%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment